featured
ASCO 2019: FOxTROT Trial Suggests Neoadjuvant Approach Improves Outcomes in Colon Cancer
But the failure to reach statistical significance calls into question whether this approach should be adopted as the gold standard
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.